BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33578522)

  • 1. Hydronephrosis in patients with cervical cancer is an indicator of poor outcome: A nationwide population-based retrospective cohort study.
    Yang YR; Chen SJ; Yen PY; Huang CP; Chiu LT; Lin WC; Chen HY; Chen YH; Chen WC
    Medicine (Baltimore); 2021 Feb; 100(6):e24182. PubMed ID: 33578522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of chronic kidney disease in patients with kidney stones-a nationwide cohort study.
    Chuang TF; Hung HC; Li SF; Lee MW; Pai JY; Hung CT
    BMC Nephrol; 2020 Jul; 21(1):292. PubMed ID: 32698782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydronephrosis in patients with cervical cancer: an assessment of morbidity and survival.
    Patel K; Foster NR; Kumar A; Grudem M; Longenbach S; Bakkum-Gamez J; Haddock M; Dowdy S; Jatoi A
    Support Care Cancer; 2015 May; 23(5):1303-9. PubMed ID: 25339620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival Outcome of Urinary Diversion in Advanced Cervical Cancer Patients with Hydronephrosis.
    Dhani FK; Daryanto B; Seputra KP
    Asian Pac J Cancer Prev; 2023 Aug; 24(8):2641-2646. PubMed ID: 37642049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydronephrosis as a prognostic indicator of survival in advanced cervix cancer.
    Pradhan TS; Duan H; Katsoulakis E; Salame G; Lee YC; Abulafia O
    Int J Gynecol Cancer; 2011 Aug; 21(6):1091-6. PubMed ID: 21738045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hydronephrosis on survival in advanced stage cervical cancer.
    Goklu MR; Seckin KD; Togrul C; Goklu Y; Tahaoglu AE; Oz M; Ertas IE
    Asian Pac J Cancer Prev; 2015; 16(10):4219-22. PubMed ID: 26028076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hydronephrosis as a prognostic factor for patients of figo IIIB cervical cancer].
    Krynicki R; Bidziński M; Wierzba W; Panek G; Jońska J; Lindner B
    Ginekol Pol; 2003 Jan; 74(1):32-9. PubMed ID: 12715435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical implications of hydronephrosis and the level of ureteral obstruction in stage IIIB cervical cancer.
    Chao KS; Leung WM; Grigsby PW; Mutch DG; Herzog T; Perez CA
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1095-100. PubMed ID: 9539564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of sleep apnoea with chronic kidney disease in a large cohort from Taiwan.
    Chu H; Shih CJ; Ou SM; Chou KT; Lo YH; Chen YT
    Respirology; 2016 May; 21(4):754-60. PubMed ID: 26799629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are there any predictors of pyonephrosis in patients with renal calculus disease?
    Patodia M; Goel A; Singh V; Singh BP; Sinha RJ; Kumar M; Dalela D; Sankhwar SN
    Urolithiasis; 2017 Aug; 45(4):415-420. PubMed ID: 27822582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predialysis chronic kidney disease correlates with increased risk of pyogenic liver abscess: a population-based cohort study.
    Lai SW; Lin CL; Liao KF
    Eur J Clin Invest; 2017 Oct; 47(10):694-701. PubMed ID: 28771692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary Primary Malignancy Risk in Patients With Cervical Cancer in Taiwan: A Nationwide Population-Based Study.
    Teng CJ; Huon LK; Hu YW; Yeh CM; Chao Y; Yang MH; Chen TJ; Hung YP; Liu CJ
    Medicine (Baltimore); 2015 Oct; 94(43):e1803. PubMed ID: 26512575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urologic complications among women with advanced cervical cancer at a tertiary referral hospital in Uganda.
    Atuhairwe S; Busingye RB; Sekikubo M; Nakimuli A; Mutyaba T
    Int J Gynaecol Obstet; 2011 Dec; 115(3):282-4. PubMed ID: 21937039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and associated relating factors in patients with hereditary retinal dystrophy: a nationwide population-based study in Taiwan.
    Woon PY; Chien JY; Wang JH; Chou YY; Lin MC; Huang SP
    BMJ Open; 2022 Apr; 12(4):e054111. PubMed ID: 35396285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, management, and sequelae of ureteric obstruction in women with cervical cancer.
    Maguire PJ; Sobota A; Mulholland D; Ryan JM; Gleeson N
    Support Care Cancer; 2020 Feb; 28(2):725-730. PubMed ID: 31129761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ureteral stent placement and percutaneous nephrostomy in the management of hydronephrosis secondary to cervical cancer.
    Tan S; Tao Z; Bian X; Zhao Y; Wang N; Chen X; Wu B
    Eur J Obstet Gynecol Reprod Biol; 2019 Oct; 241():99-103. PubMed ID: 31484100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trend and survival outcome in Taiwan cervical cancer patients: A population-based study.
    Kau YC; Liu FC; Kuo CF; Huang HJ; Li AH; Hsieh MY; Yu HP
    Medicine (Baltimore); 2019 Mar; 98(11):e14848. PubMed ID: 30882680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic radiotherapy in patients with hydronephrosis in stage IIIB cancer of the cervix: renal effects and the optimal timing for urinary diversion?
    Horan G; McArdle O; Martin J; Collins CD; Faul C
    Gynecol Oncol; 2006 Jun; 101(3):441-4. PubMed ID: 16337996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Traditional Chinese medicine decreases the obstructive uropathy risk in uterovaginal prolapse: A nationwide population-based study.
    Chang YJ; Chen WC; Chiang JH; Su YC; Tsai KS; Man KM; Tsai MY; Chen YH; Chen HY
    Medicine (Baltimore); 2018 Sep; 97(38):e12369. PubMed ID: 30235697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of venous thromboembolism in cervical cancer: a nationwide population-based study.
    Tsai SJ; Ruan YX; Lee CC; Lee MS; Chiou WY; Lin HY; Hsu FC; Su YC; Hung SK
    BMC Res Notes; 2012 Jun; 5():316. PubMed ID: 22721503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.